# Björn Eliasson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bjorn-eliasson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,858 |
| Field | Diabetes Treatment and Management |
| h-index | 76 |
| i10-index | 243 |
| Last Known Institution | Sahlgrenska University Hospital |
| OpenAlex ID | https://openalex.org/A5061198575 |
| ORCID iD | 0000-0003-2569-4160 |
| Works | 444 |

## Researcher papers

Showing 12 of 14.

- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/risk-factors-mortality-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes](https://scholariq.org/papers/mortality-and-cardiovascular-disease-in-type-1-and-type-2-diabetes/)
- [Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study](https://scholariq.org/papers/excess-mortality-and-cardiovascular-disease-in-young-adults-with-type-1-diabetes/)
- [Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks](https://scholariq.org/papers/age-at-diagnosis-of-type-2-diabetes-mellitus-and-associations-with/)
- [One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients](https://scholariq.org/papers/one-year-treatment-with-exenatide-improves-cell-function-compared-with-insulin/)
- [Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study](https://scholariq.org/papers/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-serious-adverse-events/)
- [The Lancet Commission on diabetes: using data to transform diabetes care and patient lives](https://scholariq.org/papers/the-lancet-commission-on-diabetes-using-data-to-transform-diabetes-care-and/)
- [SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe](https://scholariq.org/papers/score2-diabetes-10-year-cardiovascular-risk-estimation-in-type-2-diabetes-in/)
- [Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial](https://scholariq.org/papers/anti-interleukin-21-antibody-and-liraglutide-for-the-preservation-of-cell/)
- [Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study](https://scholariq.org/papers/cardiovascular-disease-and-mortality-in-patients-with-type-2-diabetes-after/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

## Researcher university

- [Sahlgrenska University Hospital](https://scholariq.org/institutions/sahlgrenska-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.